Agree with you bgpany2021 as I am also a LT holder and am getting discouraged by lack of progress in the R&D space.
I had a look at some old presentations earlier which had hernia device in market in 2019 and breast sling in 2021.
I understand these are complex programmes of work and timelines can move but 5 years with what seems little progress or updates? Especially with what seems a growing R&D function at PNV. I thought the new CEO would be accelerating in this space but I'm yet to be convinced, at least be a bit transparent with what's going on and why they're at least 5 years behind schedule.
Medtronic has entered the market for resorbable mesh Ventral Hernia Repair, page-13
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.53 |
Change
-0.015(0.59%) |
Mkt cap ! $1.760B | |||
| Open | High | Low | Value | Volume |
| $2.55 | $2.56 | $2.52 | $1.081M | 426.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 22442 | $2.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.53 | 20063 | 39 |
View Market Depth
| Last trade - 13.01pm 13/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |